A man receives a Sinopharm vaccine at a restaurant in Kragujevac, Serbia, on May 4. The global gaps in vaccine supply that Beijing is helping to fill are still colossal. Photo: Reuters
A man receives a Sinopharm vaccine at a restaurant in Kragujevac, Serbia, on May 4. The global gaps in vaccine supply that Beijing is helping to fill are still colossal. Photo: Reuters
Jacob Mardell
Opinion

Opinion

Jacob Mardell

WHO nod is a major credibility boost for Beijing and Chinese pharmaceuticals

  • Rather than political leverage, this reputational gain is the main prize of Chinese vaccine diplomacy and supports Beijing’s aspirations to global leadership
  • Western competitors looking to challenge Beijing should do more to provide equitable vaccine access

A man receives a Sinopharm vaccine at a restaurant in Kragujevac, Serbia, on May 4. The global gaps in vaccine supply that Beijing is helping to fill are still colossal. Photo: Reuters
A man receives a Sinopharm vaccine at a restaurant in Kragujevac, Serbia, on May 4. The global gaps in vaccine supply that Beijing is helping to fill are still colossal. Photo: Reuters
READ FULL ARTICLE